28
Views
6
CrossRef citations to date
0
Altmetric
Miscellaneous

Activators of the nitric oxide sensor, soluble guanylate cyclase

Pages 1765-1770 | Published online: 25 Feb 2005

Bibliography

  • KO F-N, WU C-C, KUO S-C et al.: YC-1, a novel activator of platelet guanylate cyclase. Blood (1994) 84:4226–4233.
  • •Original publication on YC-1.
  • FRIEBE A, KOESLING D: Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol (1998) 53:123–127.
  • STONE JR, MARLETTA MA: Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem. Biol. (1998) 5:255–261.
  • HOENICK AM, BECKER EM, APELER H et al.: Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide and carbon monoxide. J. Mol. Med. (1999) 77:14–23.
  • GALLE J, ZABEL U, HeBNER U et al.: Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br. J Pharmacol (1999) 127:195–203.
  • •Details of the phosphodiesterase activity of YC-1.
  • WALDMAN SA, MURAD F: Cyclic GMP synthesis and function. Pharmacol. Rev. (1987) 39:163–196.
  • HOBBS AJ: Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol. Sci. (1997) 18:484–491.
  • DENNINGER JW, MARLETTA MA: Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta (1999) 1411:334–350.
  • HARDY P, ABRAN D, HOU, X et al.: A major role for prostacyclin in nitric oxide-induced ocular vasore-lax ation in the piglet. Circ. Res. (1998) 83:721–729.
  • BRANDISH PE, BUECHLER W, MARLETTA MA: Regenera-tion of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin. Biochemistry (1998) 37:16898–16907.
  • MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. (1991) 43:109–142.
  • MONCADA S, HIGGS EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB (1995) 9:1319–1330.
  • KOESLING D: Modulators of soluble guanylyl cyclase. Naunyn Schmiedebergs Arch. Pharmacol. (1998) 358:123–126.
  • GARTHWAITE J, SOUTHAM S, BOULTON CL et al.: Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1 H41, 2,41ox adiazolo [4,3-a] quinoxalin-1 -one. Mol. Pharmacol. (1995) 48:184–188.
  • •Original reporting of OQD and its characterisation.
  • FEELISCH M: The use of nitric oxide donors in pharma-cological studies. Naunyn Schmiedebergs Arch. Pharmacol. (1998) 358:113–122.
  • BUECHLER WA, NAKANE M, MURAD F: Expression ofsoluble guanylate cyclase activity requires both enzyme subunits. Biochem. Biophys. Res. Commun. (1991) 174:351–357.
  • ZABEL U, WEEGER M, LA M: Human soluble guanylatecyclase: functional expression and revised isoenzyme family. Biochem. 1 (1998) 335:51–57.
  • RUSSWURM M, BEHRENDS S, HARTENECK C et al: Functional properties of a natural occurring isoform of soluble guanylyl cyclase. Biochem. 1 (1998) 335:125–130.
  • BUDWORTH J, MEILLERAIS S, CHARLES I et al: Tissuedistribution of the human soluble guanylate cyclases. Biochem. Biophys. Res. Commun. (1999) 263 :696–701.
  • BELLAMY TC, WOOD J, GOODWIN DA et al: Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. ScL USA (2000) 97:2928–2933.
  • ••Details the differential control of cGMP levels in differenttissues.
  • ZHAO Y, SCHELVIS JPM, BABCOCK GT et al.: Identifica-tion of histidine 105 in the 131 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry (1998) 37:4502–4509.
  • STONE JR, MARLETTA MA: Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry (1996) 35:1093–1099.
  • DEINUM G, STONE JR, BABCOCK GT et al.: Binding of nitric oxide and carbon monoxide to soluble guanylate cyclase as observed with resonance raman spectroscopy. Biochemistry (1996) 35:1540–1547.
  • DIERKS EA, HU S, VOGEL KM et al.: Demonstration of the role of scission of the proximal histidine-iron bond in the activation of soluble guanylyl cyclase through metalloporphyrin substitution studies. j Am. Chem. Soc. (1997) 1 1 9:7316–7323.
  • ZHAO Y, HOGANSON C, BABCOCK GT et al.: Structural changes in the heme proximal pocket induced by nitric oxide binding to soluble guanylate cyclase. Biochemistry (1998) 37:12458–12464.
  • STONE JR, MARLETTA MA: Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry (19 9 4) 33:5636-5640.
  • LUCAS KA, PITARI GM, KAZEROUNIAN S et al.: Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. (2000) 52:375–414.
  • ••Recent comprehensive review on guanylyl cyclases andcGMP signalling.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.